Related Experiment Video
Updated: Oct 25, 2025

Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons
Published on: July 13, 2015
Don't shoot the messenger… shoot the reader
Mariavittoria Pizzinga1, Robert F Harvey1, Angela Rubio1
1MRC Toxicology Unit, University of Cambridge, Tennis Court Rd., Cambridge, CB2 1QW, UK.
Abstract:
Einstein et al. (2021) uncover a novel role for the RNA-binding protein YTHDF2, one of the m6A reader proteins, in TNBC proliferation and survival. This study demonstrates the clinical potential of targeting a specific reader protein in the treatment of breast cancer.
Insights
Researchers found that the YTHDF2 protein, an m6A reader, is crucial for triple-negative breast cancer (TNBC) growth and survival. Targeting this specific protein shows promise for new breast cancer treatments.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Triple-negative breast cancer (TNBC) is an aggressive subtype with limited targeted therapies.
- RNA modifications, particularly N6-methyladenosine (m6A), are increasingly recognized as key regulators in cancer.
- m6A 'reader' proteins play critical roles in interpreting these epigenetic marks.
Purpose of the Study:
- To investigate the function of the m6A reader protein YTHDF2 in TNBC.
- To determine the role of YTHDF2 in TNBC cell proliferation and survival.
- To explore the therapeutic potential of targeting YTHDF2 in TNBC.
Main Methods:
- Analysis of YTHDF2 expression in TNBC tissues and cell lines.
- Functional assays including cell proliferation, apoptosis, and migration assays.
- Investigating the downstream molecular mechanisms regulated by YTHDF2.
Main Results:
- YTHDF2 is upregulated in TNBC and significantly correlates with poor prognosis.
- Depletion of YTHDF2 inhibits TNBC cell proliferation, induces apoptosis, and reduces tumor growth in vivo.
- YTHDF2 regulates key oncogenic pathways involved in TNBC progression.
Conclusions:
- YTHDF2 is a critical driver of TNBC proliferation and survival.
- Targeting YTHDF2 represents a promising therapeutic strategy for TNBC.
- Understanding the role of m6A readers offers new avenues for breast cancer treatment.
Related Concept Videos
Nonsense-mediated mRNA Decay
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Reporter Genes
Groupthink
Self-Presentation: Self-Monitoring and Self-Handicapping
Milgram's Obedience to Authority

